Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Additional Value of Deanxit in Tinnitus Patients Treated With Rivotril

NCT00841230 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.

NCT NCT00841230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00841230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Additional Value of Deanxit in Tinnitus Patients Treated With Rivotril
Lead sponsor
University Hospital, Antwerp
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2009
Completion date
July 31, 2009
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tinnitus